# Bio Business > Bio Business Bio Business Commentary on the business of drug discovery and other life science industries. Friday, June 4, 2021 US, EU seek to stifle biotech exits A novel antitrust strategy by the Biden Administration’s Federal Trade Commission and the EU is seeking to end an acquisition by Illumina that would accelerate the availability of a cell free cancer screening. More seriously, if widely adopted, it would make it much harder for successful startups to exit — and thus for them to raise money and be formed in the first place. Location: Global ## Categories - Other Businesses & Services ## Documents - [Business profile](https://directory.websdocs.com/business/bio-business) - [Directory JSON](https://directory.websdocs.com/business/bio-business.json) - [Schema.org JSON-LD](https://directory.websdocs.com/business/bio-business/schema.jsonld) - [Directory sitemap](https://directory.websdocs.com/sitemap.xml) - [Directory discovery manifest](https://directory.websdocs.com/.well-known/asg-directory.json) - [Directory OpenAPI](https://directory.websdocs.com/api/openapi.json) - [Official website](https://biobiz.blogspot.com/)